Â鶹Éç

Disclosure UK

Disclosure UK

The relationship between the pharmaceutical industry and healthcare professionals (HCPs) and healthcare organisations (HCOs) plays a vital role in the development and deliveryÌýof life-enhancing and life-saving medicines.Ìý

It is a relationship thatÌýwe are proud of. At the core of the relationship is sharing knowledge to improve outcomes for patients. We want to ensure that patients and othersÌýhave confidence that this relationship is open and transparent and this is why the pharmaceutical industry is taking the lead on disclosing details of payments and otherÌýbenefits in kindÌýmade by industry to HCPs and HCOs.

This information will be published on theÌýdatabase - Disclosure​ UK.Ìý

Disclosure UK database

Ìý

Disclosure UK is part of aÌýÌýto increase transparency between pharmaceutical companies and the doctors, nurses, pharmacists and other health professionals andÌýorganisations it works with.

Explore the data further

As well as searching Disclosure UK, you can also review each pharmaceutical company’s methodological note or download the full dataset by year.

2025 timeline for 2024 disclosure data

Submission deadline for companies abiding by the Â鶹ÉçCode of Practice: 14:00 GMT Friday 28 March 2025

Publication of 2024 data on Disclosure UK: Friday 27 June 2025

See also, the Â鶹ÉçCode of Practice and supplementary information to clause 31.1 regarding disclosure timelines.

Deadline 871X581
Pfizer Doctor

European Disclosure Gateway

To improve access to European data, the pharmaceutical industry has voluntarily created this single point of access to help any interested stakeholder navigate the publicly available data across all EFPIA Members countries whether hosted on individual company websites or centralised on national platforms.

Ìý

Disclosure UK publications